Zobrazeno 1 - 10
of 240
pro vyhledávání: '"AM Stoppa"'
Autor:
M. Roussel, M. Pirotte, R. Gounot, K. Queru, O. Rizzo, B. Royer, S. Harel, E. Desport, A. Huart, M. Niault, L. Karlin, O. Decaux, T. Chalopin, B. Carpentier, M. Macro, M. Vignon, E. Chalayer, AM. Stoppa, F. Bridoux, A. Jaccard
Publikováno v:
HemaSphere, Vol 7, Iss S2, Pp 4-4 (2023)
Externí odkaz:
https://doaj.org/article/d6dd3564b5bf443c9e7c1532346c96ad
Autor:
B Richard, MC Launay-Iliadis, A Iliadis, S Just-Landi, D Blaise, AM Stoppa, P Viens, MH Gaspard, D Maraninchi, JP Cano, Y Carcassonne
Publikováno v:
British Journal of Cancer
We have studied the pharmacokinetics of mitoxantrone in cancer patients. Two regimens were used: eight women (10 kinetics) received a 10 min i.v. infusion of 12 mg m-2 of mitoxantrone; seven women (seven kinetics) received high-dose mitoxantrone asso
Autor:
Régis Costello, Blaise D, Jacquemier J, Monges G, Am, Stoppa, Viens P, Olive D, Bouabdallah M, Brandely, Ja, Gastaut
Publikováno v:
Europe PubMed Central
Autor:
Jl, Harousseau, Attal M, Divine M, Noel Milpied, Marit G, Leblond V, Am, Stoppa, Jh, Bourhis, Caillot D, Boasson M
Publikováno v:
Europe PubMed Central
The optimal source of stem cells is a controversial issue in the field of autologous stem cell transplantation. A comparison of autologous bone marrow transplantation (BMT) and peripheral blood stem cell transplantation (PBSCT) after first remission
Autor:
Norbert Vey, Blaise D, Am, Stoppa, Bouabdallah R, Lafage M, Sainty D, Cowen D, Viens P, Lepeu G, Ap, Blanc
Publikováno v:
Europe PubMed Central
Over a 10 year period, we transplanted 63 patients with acute lymphoblastic leukaemia (ALL) who had achieved first complete remission (CR). All were15 years old and 45 (71%) had at least one poor prognostic factor. Twenty-nine patients with a suitabl
Autor:
Michallet M, Corront B, Jl, Bosson, Molina L, bernard peissel, Maraninchi D, Reiffers J, Chabannon C, Mh, Gaspard, Am, Stoppa
Publikováno v:
Europe PubMed Central
Allogeneic bone marrow transplantation is a therapeutic option for many hematological malignancies. Graft-versus-host disease (GVHD) remains one of the major complications and has a high mortality rate. The pathophysiological mechanisms involved are
Autor:
Blaise D, Am, Stoppa, Olive D, Brandely M, Pierre Tiberghien, Attal M, Attal J, Reiffers J, Demeocq F, Jl, Pico
Publikováno v:
Europe PubMed Central
Publikováno v:
Transfusion Clinique et Biologique. 5:56s-56s
Autor:
Am. Stoppa, Eric Solary, C. Ramazeilles, Agnès Guerci, H. Rochant, I. Blot, Philippe Travade, M.P. Schuller, E. Baumelou, T de Revel, Francois Dreyfus, Frédéric Maloisel, Dominique Bordessoule, Pierre Fenaux, Jean Briere, Albert Najman, Michel Leporrier, S. Chevret, Bruno Varet, Christine Chomienne
Publikováno v:
Leukemia Research. 21:S40
Publikováno v:
La Revue de Médecine Interne. 17:S164